1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Emmaus Life Sciences Inc (EMMA) Chairman and CEO Yutaka Niihara Bought $65,910 of Shares

August 21, 2019 | About:

Chairman and CEO of Emmaus Life Sciences Inc (30-Year Financial, Insider Trades) Yutaka Niihara (insider trades) bought 19,500 shares of EMMA on 08/21/2019 at an average price of $3.38 a share. The total cost of this purchase was $65,910.

MYnd Analytics Inc is a cloud-based predictive analytics company. It provides clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, bipolar disorder and post-traumatic stress disorder. Emmaus Life Sciences Inc has a market cap of $159.950 million; its shares were traded at around $3.37 with and P/S ratio of 2.69. Emmaus Life Sciences Inc had annual average EBITDA growth of 35.40% over the past five years. GuruFocus has detected 2 severe warning signs with Emmaus Life Sciences Inc. .

CEO Recent Trades:

  • Chairman and CEO, 10% Owner Yutaka Niihara bought 19,500 shares of EMMA stock on 08/21/2019 at the average price of $3.38. The price of the stock has decreased by 0.3% since.

For the complete insider trading history of EMMA, click here

.

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)